FDA Inspection
OrBion Pharmaceuticals Private LimitedOrBion Pharmaceuticals Private Limited – FDA Inspection, Dec 15, 2016
Record Details
This FDA Inspection record concerns OrBion Pharmaceuticals Private Limited, with an inspection on December 15, 2016, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- December 15, 2016
- Product Type
- Human Drugs
View Company Profile
ID · 64e56631-ec0d-4469-aff9-f319b8ff31b9
Inspection Facts
- Inspection number
- 1001296
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of OrBion Pharmaceuticals Private Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 27, 2025 | OAI | Generic Drug Evaluation | |
| May 10, 2024 | Not classified | Office of Inspections and Investigations | |
| September 8, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for OrBion Pharmaceuticals Private Limited
- FDA Inspection 1289382 - 2025-10-27
- FDA Inspection 1240651 - 2024-05-10
- FDA Inspection 1217144 - 2023-09-08
- FDA Inspection 1091278 - 2019-05-31
- FDA Inspection 934390 - 2015-06-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.